Friday, February 17, 2023 9:24:33 AM
BIOLASE TO PRESENT AT THE THIRD ANNUAL WINTER WONDERLAND BEST IDEAS VIRTUAL INVESTOR CONFERENCE
Source: PR Newswire (US)
LAKE FOREST, Calif., Feb. 16, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has been invited to present at the Third Annual Winter Wonderland Best Ideas Virtual Investor Conference being held February 21–24, 2023. John Beaver, President and Chief Executive Officer, and Jennifer Bright, Chief Financial Officer, will present at the conference and host virtual meetings with institutional investors and analysts throughout the event.
?
BIOLASE is scheduled to present on Tuesday, February 21, 2023, at 2:00 p.m. PT (5:00 p.m. ET). Management will be available for one-on-one meetings from February 23–24, 2023. The presentation will be webcast live and available for replay at ir.biolase.com.
To receive additional information, request an invitation, or schedule a one-on-one meeting, please email angie.wright@issuerdirect.com.
Investors can register here for the conference.
About BIOLASE
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 301 patented and 28 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. From 1998 through December 31, 2021, BIOLASE has sold over 43,300 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.
For further information, please contact:
EVC Group LLC
Michael Polyviou / Todd Kehrli
(732) 933-2754
mpolyviou@evcgroup.com / tkehrli@evcgroup.com
? View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-to-present-at-the-third-annual-winter-wonderland-best-ideas-virtual-investor-conference-301749428.html
SOURCE BIOLASE, Inc.
?
Copyright 2023 PR Newswire
Recent BIOL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:05:18 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/08/2024 11:31:05 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:14:14 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/23/2024 09:05:29 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/21/2024 09:39:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 12:01:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:15:33 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 06:10:34 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/14/2024 05:15:26 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:03:55 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 01:44:40 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/07/2024 11:11:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 11:04:56 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/31/2024 02:57:42 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 10:01:33 PM
- BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024 • PR Newswire (US) • 01/29/2024 11:30:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/24/2024 10:21:31 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/19/2024 11:09:03 AM
- BIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023 • PR Newswire (US) • 01/08/2024 09:05:00 PM
- BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD • PR Newswire (US) • 01/03/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 09:05:28 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/26/2023 10:22:25 PM
- BIOLASE RECEIVES TOP WORKPLACES 2023 AWARD • PR Newswire (US) • 12/14/2023 09:05:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM